Biopharma Stocks Mired in Macro-Risk Off…Update-2…”Future of Biotech” from Barrons’s
With biotech in a funk this timely article from Barron's should help. Barron's to the Rescue: Future of Biotech, article offers picks from a new Roundtable (above link may not open because requires subscription) Some of the picks ASND, MDCO,MGTX,NVTA,RGNX, SRPT, VRTX ========= Update-2 9/28...
What Did I Miss While I was on Vacation in September: Biotech Wrap-Up in a Sideways Market…Update-1
Update-1 A bit of a sell-off on end of week option expirations and cancellation of China visit to farm Bureau in MT. NAZ down 0.8%, S&P down 0.5%. Less reaction to China news now? Can biotech rally as contrian play to tech and industrials? tape in biotech was better than overall market....
Large Cap Biopharmaceuticals: 2019 Performance Snapshot-Can the XBI remain a good play for Q4?..Update-1.
Update-1 Aug 31 Saturday-Biotech Stocks on the Road to Nowhere? IBB flat for the week at $102.89, down 5 pts for the month. XBI flat for the week at $80.37 down 7 pts for the month. Alexion (ALXN) down 10.17% to $100.76 on patent challenge from Amgen (AMGN) on Solaris, the ALXN blockbuster...
Rayno Biobeat #2: A Wicked Week with Bearish Trends in Biopharma-Update 3.. ALXN, Trade War Talk
Update -3 Bearish trends in biopharma continue with both the IBB and XBI down with 30 min of trading to go. We will do a review of the healthcare sector later this week continuing the theme after the AACC of the need for diversification within healthcare e.g. medtech, diagnostics and tools....